Ticker Details
Baxter International Inc. Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$9.91B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.73 | 0.94%
Avg Daily Range (30 D):	$0.36 | 2.00%
Avg Daily Range (90 D):	$0.35 | 1.89%

Institutional Daily Volume
Avg Daily Volume:	3.45M
Avg Daily Volume (30 D):	6.03M
Avg Daily Volume (90 D):	7.25M

Trade Size
Avg Trade Size (Sh.):	147
Avg Trade Size (Sh.) (30 D):	112
Avg Trade Size (Sh.) (90 D):	114

Institutional Trades
Total Institutional Trades:	63,791
Avg Institutional Trade:	$3.83M
Avg Institutional Trade (30 D):	$5.01M
Avg Institutional Trade (90 D):	$4.78M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	11

Market Closing Trades
Avg Closing Trade:	$20.37M
Avg Closing Trade (30 D):	$24.4M
Avg Closing Trade (90 D):	$28.15M
Avg Closing Volume:	402.83K

News

May 7, 2026 @ 8:14 AM Becton Dickinson at 13x Earnings: MedTech’s... Source: Gurufocus

Apr 9, 2026 @ 8:57 AM Robotic Pharmacy Prescription Market Research and ... Source: Researchandmarkets.Com

Mar 25, 2026 @ 12:01 PM EXCLUSIVE: Petrochemical Crunch From Iran War Isn'... Source: Eva Mathew

Mar 24, 2026 @ 5:24 PM Manufacturing Disruption Hits Baxter Cancer Drug S... Source: Vandana Singh

Mar 17, 2026 @ 9:26 AM The ’Battleship’ Plan for 8.2%+ Divi... Source: Brett Owens

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.87	$-2.2	$-1.87
Diluted EPS	$-1.87	$-2.2	$-1.87
Revenue	$11.24B	$2.97B	$11.24B
Gross Profit	$3.38B	$577M	$3.38B
Net Income / Loss	$-957M	$-1128M	$-957M
Operating Income / Loss	$-308M	$-729M	$-308M
Cost of Revenue	$7.87B	$2.4B	$7.87B
Net Cash Flow	$-530M	$156M	$-530M
PE Ratio

Splits
May 31, 2001	2:1